John S. Kovach is President & 10% at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB). They have made 1 open-market trade across 1 company since 2020, most recently 2020-11-30.
CIK 0001368556
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LIXT | BUY | 2020-11-30 | 2020-12-02 | $4.75 | $100K | -7.5% | -13.5% | +10.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.